Correlation Study of Four HER2 Immunohistochemical Staining Assays in Breast Cancer and Changes of Heterogeneity Patterns

被引：0
|
作者：
Yue, Meng [1 ]
Wu, Si [1 ]
Huang, Liujing
Lei, Ming
Liu, Hongbo [1 ]
Wei, Weiwei
Liu, Yueping [1 ]
机构：
[1] Hebei Med Univ, Hosp 4, Shijiazhuang, Peoples R China
来源：
LABORATORY INVESTIGATION | 2024年 / 104卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
264
引用
收藏
页码：S322 / S324
页数：3
相关论文
共 50 条
  • [21] Testing for HER2 in breast cancer.: A concordance study including four different assays using TMA technology
    Brugmann, Anja
    Lelkaitis, Giedrius
    Nielsen, Soren
    Gadgaard, Kirsten
    Jensen, Vibeke
    APMIS, 2008, 116 (03) : 246 - 247
  • [22] HER2 Gene Protein Assay Is Useful to Determine HER2 Status and Evaluate HER2 Heterogeneity in HER2 Equivocal Breast Cancer
    Hou, Yanjun
    Nitta, Hiroaki
    Li, Zaibo
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2017, 147 (01) : 89 - 95
  • [23] Tumoral heterogeneity and HER2 status in invasive breast cancer
    Asselah, J.
    Cottu, P.
    Vincent-Salomon, A.
    Dieras, V
    Mignot, L.
    BULLETIN DU CANCER, 2007, 94 (06) : 568 - 568
  • [24] HER2 Intratumoral Heterogeneity in Breast Cancer: Clinicopathologic Characteristics
    Muller, Kristen E.
    Marotti, Jonathan
    Tafe, Laura
    MODERN PATHOLOGY, 2018, 31 : 93 - 93
  • [25] HER2 Intratumoral Heterogeneity in Breast Cancer, an Evolving Concept
    Hou, Yanjun
    Nitta, Hiroaki
    Li, Zaibo
    CANCERS, 2023, 15 (10)
  • [26] HER2 Intratumoral Heterogeneity in Breast Cancer: Clinicopathologic Characteristics
    Muller, Kristen E.
    Marotti, Jonathan
    Tafe, Laura
    LABORATORY INVESTIGATION, 2018, 98 : 93 - 93
  • [27] Correlation between HER2/neu status with immunohistochemical analysis and serum HER2 concentration with ADVIA Cencaur automated immunoassay in breast cancer
    Lee, J.
    Ahn, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [28] Interassay comparison of four clinically approved HER2 immunohistochemistry assays in primary breast cancer and their metastasis
    Hempenius, M. A.
    Zwager, M. C.
    den Bakker, M. A.
    Coster-Heerema, M.
    de Vries, E. G. E.
    Schroder, C. P.
    't Hart, N. A.
    van der Vegt, B.
    VIRCHOWS ARCHIV, 2024, 485 : S3 - S3
  • [29] Genetic heterogeneity of HER2 in breast cancer: impact on HER2 testing and its clinicopathologic significance
    Yang, Yi-ling
    Fan, Yu
    Lang, Rong-gang
    Gu, Feng
    Ren, Mei-Jing
    Zhang, Xin-Min
    Yin, Dong
    Fu, Li
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (03) : 1095 - 1102
  • [30] Genetic heterogeneity of HER2 in breast cancer: impact on HER2 testing and its clinicopathologic significance
    Yi-ling Yang
    Yu Fan
    Rong-gang Lang
    Feng Gu
    Mei-Jing Ren
    Xin-Min Zhang
    Dong Yin
    Li Fu
    Breast Cancer Research and Treatment, 2012, 134 : 1095 - 1102
12345